BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Notice of Annual General Meeting to be held on August 25, 2025
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Balaxi Pharmaceuticals has informed the exchange about its 82nd Annual General Meeting scheduled for Monday, August 25, 2025, at 11:00 a.m. IST, to be held through video conferencing. The cut-off date for e-voting eligibility is August 15, 2025, and remote e-voting will run from August 22 to August 24, 2025. The AGM will cover four items: adoption of audited standalone and consolidated financial statements for FY 2024-25, re-appointment of Mrs. Minoshi Maheshwari (DIN: 01575975) as a director liable to retire by rotation, and appointment of M/s. BVR & Associates Company Secretaries LLP as Secretarial Auditors for five consecutive years (FY 2025-26 to FY 2029-30) at a fee of Rs. 55,000 per annum plus taxes. Mrs. Minoshi Maheshwari holds 5,27,900 equity shares (0.96% of total shareholding) and is the spouse of Managing Director Mr. Ashish Maheshwari. The AGM notice along with the Annual Report 2024-25 has been made available on the company's website and through electronic mode to members.
This is a routine AGM notice filing with no material impact on shareholders. Investors should note the e-voting cut-off date (August 15, 2025) if they wish to participate. The resolutions are standard corporate items — approval of financials, a routine director re-appointment, and appointment of secretarial auditors — and are unlikely to move the stock price.